Primary progressive aphasia and the growing role of biomarkers in neurological diagnosis

Annals of Neurology

Volumn 64, Issue 4, 2008, Pages 361-364

  Cummings, Jeffrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL FEATURE; DEMENTIA; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EDITORIAL; NEUROPATHOLOGY; ONSET AGE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL;

APHASIA, PRIMARY PROGRESSIVE; BIOLOGICAL MARKERS; HUMANS;

EID: 55849101658     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21487     Document Type: Editorial

References (10)

1. Cairns NJ, Bigio EH, Macxkenzie IRA, et al. Neuropathologic diagnostic and nosologic criteria for frontomeporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degneration. Acta Neuropathol 2007;114:5-22.
2. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
3. Kumar-Singh S, Van Broeckhaven C. Frontotemporal lobar degeneration: current concepts in the light of recent advances. Brain Pathol 2007;17:104-113.
4. Boeve B, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol 2008;65:460-464.
5. Rabinovici GD, Jagust WJ, Furst AJ, et al. Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008;64:388-401.
6. Mesulam MM. Slowlt orogressive aphasia without generalized dementia. Ann Neurol 1982;11:582-598.
7. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335-346.
8. Klunk WE, Engler H, Norberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319.
9. Ikonomovic MD, Klunk WE, Abrahamson EE, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008;131(pt 6):1630-1645.
10. Roberson ED, Scearce-Levie K, Palop JJ, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007;316:750-754.